On September 20, please join Treatment Action Group, Dr. Shelly Karuna, and Dr. Karine Dubé for a webinar on the next generation of bnAbs trial design and ethics related to ATIs in HIV vaccine and cure research.
On May 18, 2022, Treatment Action Group (TAG), the Black AIDS Institute (BAI), and the Southern AIDS Coalition (SAC) participated in this fun and informative Instagram Live discussion commemorating HIV Vaccine Awareness. Day.
The 2022 Community HIV Cure Research Workshop took place virtually this year due to the ongoing COVID-19 pandemic. There were two sessions, the first on Tuesday February 8th and the second on Tuesday March 1st.
Engagement of affected communities in research is vital to ensuring that the science is ethical and responsive to community priorities and needs. This module covers the history of community-based HIV research advocacy and outlines principles and best practices for community…
Some HIV cure research studies ask participants to temporarily stop antiretroviral therapy, which is referred to as an analytical treatment interruption (ATI). This module explains the use of ATIs in HIV cure research and covers what is currently known about…
An overview of current knowledge regarding how HIV persists in the body despite suppression of viral load by antiretroviral therapy. Understanding the mechanisms by which HIV persists is considered key to developing curative interventions that would prevent the virus rebounding…
Scientists are pursuing multiple approaches with the aim of developing interventions capable of curing HIV or keeping HIV durably suppressed in the absence of antiretroviral therapy. This module provides an overview of the many strategies that are currently under investigation…
Ethics are a cornerstone of all scientific research, providing principles by which studies should be conducted to ensure that participants are properly informed and that any risks are justified and acceptable. This module provides background on research ethics and covers…
An introductory overview of the research effort to develop a cure for HIV infection. Topics covered include terms and definitions used in HIV cure research, the reasons why a cure is needed, evidence supporting that a cure is possible, and…
Treatment Action Group (TAG) welcomes and celebrates the U.S. Food and Drug Administration’s (FDA) approval of Apretude brand cabotegravir, the first injectable medication for use as pre-exposure prophylaxis (PrEP) to reduce the risk of HIV transmission.